BPG is committed to discovery and dissemination of knowledge
Welcome to the World Journal of Diabetes

The World Journal of Diabetes (WJD) is a leading academic journal devoted to reporting the latest, cutting-edge research progress and findings of basic research and clinical practice in the field of diabetes.  It was launched on March 15, 2010 and is published monthly (12 issues annually) by BPG, the world's leading professional clinical medical journal publishing company.

We encourage diabetologists worldwide to submit manuscripts to the WJD describing their original basic or clinical research findings that are of high academic value and which report new diagnostic techniques or summarize their treatment experiences.

The usual times related to all publication processes of the WJD are as follows: (1) From manuscript receipt to peer-review: 2-4 weeks; (2) From initial manuscript acceptance, with revisions, to return of the revised manuscript from the authors: 4-5 weeks; (3) From return of the revised manuscript from the authors to final acceptance: 1-2 weeks; (4) From final acceptance to an article in press: 2 days; and (5) From article in press designation to formal release of the electronic version and all online documentation: 2-9 weeks. The WJD’s acceptance rate: 57%. Submit here >>

2017 Published Issues
3 2 1

Lu Qi, MD, PhD, Associate Professor; Jingbo Zhao, PhD, Associate Professor


Emerging Sources Citation Index (Web of Science), PubMed, and PubMed Central.

Journal Metrics

There is currently no impact factor.


1948-9358 (online)

Management of critically ill patients with diabetes  
Livier Josefina Silva-Perez, Mario Alberto Benitez-Lopez, Joseph Varon, Salim Surani
World J Diabetes 8(3):89-96. Published online Mar 15, 2017. doi: 10.4239/wjd.v8.i3.89
Involvement of Cbl-b-mediated macrophage inactivation in insulin resistance  
Tomoki Abe, Katsuya Hirasaka, Takeshi Nikawa
World J Diabetes 8(3):97-103. Published online Mar 15, 2017. doi: 10.4239/wjd.v8.i3.97
Retrospective Cohort Study
Statin, testosterone and phosphodiesterase 5-inhibitor treatments and age related mortality in diabetes  
Geoffrey Hackett, Peter W Jones, Richard C Strange, Sudarshan Ramachandran
World J Diabetes 8(3):104-111. Published online Mar 15, 2017. doi: 10.4239/wjd.v8.i3.104
Prospective Study
Role of angiotensin converting enzyme and angiotensinogen gene polymorphisms in angiotensin converting enzyme inhibitor-mediated antiproteinuric action in type 2 diabetic nephropathy patients  
Neerja Aggarwal, Pawan Kumar Kare, Parul Varshney, Om Prakash Kalra, Sri Venkata Madhu, Basu Dev Banerjee, Anil Yadav, Alpana Raizada, Ashok Kumar Tripathi
World J Diabetes 8(3):112-119. Published online Mar 15, 2017. doi: 10.4239/wjd.v8.i3.112